TERAWULF INC (WULF) Fundamental Analysis & Valuation

NASDAQ:WULF • US88080T1043

14.35 USD
+0.5 (+3.61%)
At close: Mar 10, 2026
14.56 USD
+0.21 (+1.46%)
Pre-Market: 3/11/2026, 9:23:08 AM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership News

This WULF fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to WULF. WULF was compared to 277 industry peers in the Software industry. WULF has a bad profitability rating. Also its financial health evaluation is rather negative. WULF does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

1

1. WULF Profitability Analysis

1.1 Basic Checks

  • In the past year WULF has reported negative net income.
  • In the past year WULF has reported a negative cash flow from operations.
  • WULF had negative earnings in each of the past 5 years.
  • In the past 5 years WULF reported 4 times negative operating cash flow.
WULF Yearly Net Income VS EBIT VS OCF VS FCFWULF Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -50M -100M -150M -200M -250M

1.2 Ratios

  • The Return On Assets of WULF (-22.94%) is worse than 74.73% of its industry peers.
  • The Return On Equity of WULF (-227.68%) is worse than 84.12% of its industry peers.
Industry RankSector Rank
ROA -22.94%
ROE -227.68%
ROIC N/A
ROA(3y)-19.15%
ROA(5y)-19.16%
ROE(3y)-46.79%
ROE(5y)-44.08%
ROIC(3y)N/A
ROIC(5y)N/A
WULF Yearly ROA, ROE, ROICWULF Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20 -40 -60

1.3 Margins

  • WULF's Gross Margin of 50.24% is on the low side compared to the rest of the industry. WULF is outperformed by 68.59% of its industry peers.
  • WULF's Gross Margin has improved in the last couple of years.
  • The Profit Margin and Operating Margin are not available for WULF so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 50.24%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5Y12.53%
WULF Yearly Profit, Operating, Gross MarginsWULF Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200 -400 -600

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

2

2. WULF Health Analysis

2.1 Basic Checks

  • WULF does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • There is no outstanding debt for WULF. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
WULF Yearly Shares OutstandingWULF Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M
WULF Yearly Total Debt VS Total AssetsWULF Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

2.2 Solvency

  • WULF has an Altman-Z score of 1.08. This is a bad value and indicates that WULF is not financially healthy and even has some risk of bankruptcy.
  • WULF has a Altman-Z score of 1.08. This is comparable to the rest of the industry: WULF outperforms 40.43% of its industry peers.
  • WULF has a Debt/Equity ratio of 4.29. This is a high value indicating a heavy dependency on external financing.
  • WULF has a Debt to Equity ratio of 4.29. This is amonst the worse of the industry: WULF underperforms 85.56% of its industry peers.
Industry RankSector Rank
Debt/Equity 4.29
Debt/FCF N/A
Altman-Z 1.08
ROIC/WACCN/A
WACC10.71%
WULF Yearly LT Debt VS Equity VS FCFWULF Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M

2.3 Liquidity

  • WULF has a Current Ratio of 1.03. This is a normal value and indicates that WULF is financially healthy and should not expect problems in meeting its short term obligations.
  • Looking at the Current ratio, with a value of 1.03, WULF is doing worse than 72.92% of the companies in the same industry.
  • WULF has a Quick Ratio of 1.03. This is a normal value and indicates that WULF is financially healthy and should not expect problems in meeting its short term obligations.
  • WULF's Quick ratio of 1.03 is on the low side compared to the rest of the industry. WULF is outperformed by 72.20% of its industry peers.
Industry RankSector Rank
Current Ratio 1.03
Quick Ratio 1.03
WULF Yearly Current Assets VS Current LiabilitesWULF Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. WULF Growth Analysis

3.1 Past

  • The earnings per share for WULF have decreased strongly by -205.26% in the last year.
EPS 1Y (TTM)-205.26%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-262.5%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%2.43%

3.2 Future

  • The Earnings Per Share is expected to grow by 36.43% on average over the next years. This is a very strong growth
  • WULF is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 75.74% yearly.
EPS Next Y19.65%
EPS Next 2Y45.56%
EPS Next 3Y22.05%
EPS Next 5Y36.43%
Revenue Next Year112.12%
Revenue Next 2Y144.45%
Revenue Next 3Y90.44%
Revenue Next 5Y75.74%

3.3 Evolution

WULF Yearly Revenue VS EstimatesWULF Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 1B 2B 3B
WULF Yearly EPS VS EstimatesWULF Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 1 -1

More info and screens

Find the best growth stocksShow best growing peers

1

4. WULF Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for WULF. In the last year negative earnings were reported.
  • Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for WULF. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
WULF Price Earnings VS Forward Price EarningsWULF Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
WULF Per share dataWULF EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 -1 -1.5

4.3 Compensation for Growth

  • WULF's earnings are expected to grow with 22.05% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y45.56%
EPS Next 3Y22.05%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. WULF Dividend Analysis

5.1 Amount

  • WULF does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

WULF Fundamentals: All Metrics, Ratios and Statistics

TERAWULF INC

NASDAQ:WULF (3/10/2026, 10:10:50 PM)

Premarket: 14.56 +0.21 (+1.46%)

14.35

+0.5 (+3.61%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)02-26
Earnings (Next)05-07
Inst Owners79.09%
Inst Owner Change6.76%
Ins Owners6.84%
Ins Owner Change-0.83%
Market Cap6.09B
Revenue(TTM)N/A
Net Income(TTM)-563.16M
Analysts83
Price Target23.7 (65.16%)
Short Float %30.76%
Short Ratio3.16
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-7.74%
Min EPS beat(2)-39.24%
Max EPS beat(2)23.75%
EPS beat(4)1
Avg EPS beat(4)-69.46%
Min EPS beat(4)-133.63%
Max EPS beat(4)23.75%
EPS beat(8)1
Avg EPS beat(8)-79.72%
EPS beat(12)1
Avg EPS beat(12)-101.53%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-2.24%
Min Revenue beat(2)-5.47%
Max Revenue beat(2)0.98%
Revenue beat(4)1
Avg Revenue beat(4)-8.8%
Min Revenue beat(4)-21.8%
Max Revenue beat(4)0.98%
Revenue beat(8)1
Avg Revenue beat(8)-9.39%
Revenue beat(12)2
Avg Revenue beat(12)-10.38%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)4.78%
PT rev (3m)9.92%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-5.93%
EPS NY rev (1m)0%
EPS NY rev (3m)-45.59%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-5.69%
Revenue NY rev (1m)-0.32%
Revenue NY rev (3m)-2.87%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 36.31
P/FCF N/A
P/OCF N/A
P/B 24.6
P/tB 31.71
EV/EBITDA N/A
EPS(TTM)-0.58
EYN/A
EPS(NY)-0.47
Fwd EYN/A
FCF(TTM)-1.6
FCFYN/A
OCF(TTM)-0.18
OCFYN/A
SpS0.4
BVpS0.58
TBVpS0.45
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -22.94%
ROE -227.68%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 50.24%
FCFM N/A
ROA(3y)-19.15%
ROA(5y)-19.16%
ROE(3y)-46.79%
ROE(5y)-44.08%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5Y12.53%
F-Score3
Asset Turnover0.07
Health
Industry RankSector Rank
Debt/Equity 4.29
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 797.9%
Cap/Sales 357.29%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.03
Quick Ratio 1.03
Altman-Z 1.08
F-Score3
WACC10.71%
ROIC/WACCN/A
Cap/Depr(3y)543.16%
Cap/Depr(5y)N/A
Cap/Sales(3y)235.52%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-205.26%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-262.5%
EPS Next Y19.65%
EPS Next 2Y45.56%
EPS Next 3Y22.05%
EPS Next 5Y36.43%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%2.43%
Revenue Next Year112.12%
Revenue Next 2Y144.45%
Revenue Next 3Y90.44%
Revenue Next 5Y75.74%
EBIT growth 1Y-290.93%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year244.32%
EBIT Next 3Y188.82%
EBIT Next 5Y124.91%
FCF growth 1Y-1034.15%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-910.57%
OCF growth 3YN/A
OCF growth 5YN/A

TERAWULF INC / WULF FAQ

What is the ChartMill fundamental rating of TERAWULF INC (WULF) stock?

ChartMill assigns a fundamental rating of 1 / 10 to WULF.


What is the valuation status for WULF stock?

ChartMill assigns a valuation rating of 1 / 10 to TERAWULF INC (WULF). This can be considered as Overvalued.


Can you provide the profitability details for TERAWULF INC?

TERAWULF INC (WULF) has a profitability rating of 1 / 10.


How sustainable is the dividend of TERAWULF INC (WULF) stock?

The dividend rating of TERAWULF INC (WULF) is 0 / 10 and the dividend payout ratio is 0%.